Boehringer Ingelheim Prescription Medicines Advertiser Profile
Boehringer Ingelheim Prescription Medicines is part of:
Boehringer Ingelheim Prescription Medicines is part of C.H. Boehringer Sohn AG & Co KG. They spent under $100 million on advertising in digital, print, and national TV in the last year. They invest in premium ad units and advertised on over 250 different Media Properties in the last year across multiple Media formats. Boehringer Ingelheim Prescription Medicines launched and advertised 3 new products in the past twelve months.
We have 8 people on file in marketing roles at Boehringer Ingelheim Prescription Medicines, and 3 at their agencies.
We have 8 people on file in marketing roles at Boehringer Ingelheim Prescription Medicines, and 3 at their agencies.
Summary
Boehringer Ingelheim Prescription Medicines is part of C.H. Boehringer Sohn AG & Co KG. They spent under $100 million on advertising in digital, print, and national TV in the last year. They invest in premium ad units and advertised on over 250 different Media Properties in the last year across multiple Media formats. Boehringer Ingelheim Prescription Medicines launched and advertised 3 new products in the past twelve months.
We have 8 people on file in marketing roles at Boehringer Ingelheim Prescription Medicines, and 3 at their agencies.
We have 8 people on file in marketing roles at Boehringer Ingelheim Prescription Medicines, and 3 at their agencies.
MediaRadar helps advertising sales teams reach the key decision makers at brands. Our contacts database includes full names, email addresses, specialties, agency relationships and phone numbers, and we verify each contact every 90 days to ensure you have the most current information.
We have identified 11 decision makers for you to contact at Boehringer Ingelheim Prescription Medicines, including Executives, Strategists, Media Buyers and Agency contacts.
Greg D.
Lead Early Asset Value and Access - Retina (Interim)
Erick J.
Media Director
Michael L.
Director, Digital Health
Key Contacts
MediaRadar helps advertising sales teams reach the key decision makers at brands. Our contacts database includes full names, email addresses, specialties, agency relationships and phone numbers, and we verify each contact every 90 days to ensure you have the most current information.
We have identified 11 decision makers for you to contact at Boehringer Ingelheim Prescription Medicines, including Executives, Strategists, Media Buyers and Agency contacts.
Greg D.
Lead Early Asset Value and Access - Retina (Interim)
Erick J.
Media Director
Michael L.
Director, Digital Health
MediaRadar captures creative run on the top websites, magazines and national television stations for over 3 million brands. Here are 3 recent advertisements placed by Boehringer Ingelheim Prescription Medicines and its subsidiaries.
Display
Last ran on VeryWellFit on 11/1/2024.
TV
Last ran on CNN on 11/16/2024.
Print
Last ran on The American Journal of Managed Care in the 10/2024 issue.
Display
Last ran on VeryWellFit on 11/1/2024.
TV
Last ran on CNN on 11/16/2024.
Print
Last ran on The American Journal of Managed Care in the 10/2024 issue.
Recent Ad Creative
MediaRadar captures creative run on the top websites, magazines and national television stations for over 3 million brands. Here are 3 recent advertisements placed by Boehringer Ingelheim Prescription Medicines and its subsidiaries.
Display
Last ran on VeryWellFit on 11/1/2024.
TV
Last ran on CNN on 11/16/2024.
Print
Last ran on The American Journal of Managed Care in the 10/2024 issue.
Display
Last ran on VeryWellFit on 11/1/2024.
TV
Last ran on CNN on 11/16/2024.
Print
Last ran on The American Journal of Managed Care in the 10/2024 issue.
MediaRadar calculates estimated spend for the digital, print and national television campaigns that we identify using proprietary algorithms based on medium and advertisement type.
Boehringer Ingelheim Prescription Medicines Advertising Spend:
OVER $100 Million
Increased Spending YoY
- Boehringer Ingelheim Prescription Medicines recently bought a Spread print ad. See which other premium units they bought.
- Boehringer Ingelheim Prescription Medicines recently placed a direct ad on www.everydayhealth.com/cancer/guide/. See where else they recently placed direct ads.
- Boehringer Ingelheim Prescription Medicines recently placed a programmatic ad on www.youtube.com/. In the last 12 months, they have partnered with DoubleClick and 6 other providers. Which providers do they use most?
Media Spend
MediaRadar calculates estimated spend for the digital, print and national television campaigns that we identify using proprietary algorithms based on medium and advertisement type.
Boehringer Ingelheim Prescription Medicines Advertising Spend:
OVER $100 Million
Increased Spending YoY
- Boehringer Ingelheim Prescription Medicines recently bought a Spread print ad. See which other premium units they bought.
- Boehringer Ingelheim Prescription Medicines recently placed a direct ad on www.everydayhealth.com/cancer/guide/. See where else they recently placed direct ads.
- Boehringer Ingelheim Prescription Medicines recently placed a programmatic ad on www.youtube.com/. In the last 12 months, they have partnered with DoubleClick and 6 other providers. Which providers do they use most?
MediaRadar tracks new product launches across the 3 million+ brands in our database, and classifies each campaign to a specific product line using our proprietary classification methodology, giving you a deeper understanding of how a brand is allocating its advertising budgets. In the last year, we identified 27,397 new product launches overall.
Boehringer Ingelheim Prescription Medicines launched campaigns supporting 3 new product lines in the last twelve months, including SGLT2.
New Product Launches
MediaRadar tracks new product launches across the 3 million+ brands in our database, and classifies each campaign to a specific product line using our proprietary classification methodology, giving you a deeper understanding of how a brand is allocating its advertising budgets. In the last year, we identified 27,397 new product launches overall.
Boehringer Ingelheim Prescription Medicines launched campaigns supporting 3 new product lines in the last twelve months, including SGLT2.